e-learning
resources
Vienna 2003
Monday 29.09.2003
Diagnosis of tuberculosis and laboratory aspects: genetics and immunobiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic value of detecting the HLA genetic markers in patients from risk groups for TB
V. P. Chukanova, A. L. Sobkin, E. G. Fomin, L. E. Pospelov, A. L. Malenko (Moscow, Russia)
Source:
Annual Congress 2003 - Diagnosis of tuberculosis and laboratory aspects: genetics and immunobiology
Session:
Diagnosis of tuberculosis and laboratory aspects: genetics and immunobiology
Session type:
Thematic Poster Session
Number:
2149
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. P. Chukanova, A. L. Sobkin, E. G. Fomin, L. E. Pospelov, A. L. Malenko (Moscow, Russia). Prognostic value of detecting the HLA genetic markers in patients from risk groups for TB. Eur Respir J 2003; 22: Suppl. 45, 2149
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Prognostic value of HLA typing in Irish patients with pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 107s
Year: 2001
Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014
Prognostic values of biomarkers in COPD
Source: Annual Congress 2013 –Natural history of COPD: novel aspects
Year: 2013
The clinical current of tuberculosis in patients with different genetic markers
Source: Eur Respir J 2006; 28: Suppl. 50, 14s
Year: 2006
Identification of genes with diagnostic and prognostic value in lung cancer.
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Pro-adrenomedullin as prognostic marker in patients with CAP
Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers
Year: 2008
HLA-DRB1 allele frequencies in Finnish sarcoidosis patients and associations with disease prognosis
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
The peculiarities of detecting TB in risk groups and identification of high-risk groups in TB control in Ukraine
Source: Eur Respir J 2005; 26: Suppl. 49, 196s
Year: 2005
HLA-DRB1 allele distributions in Danish sarcoidosis patients. Increased prevalence of HLA-DRB1*15
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012
Determining values of prognostic factors with patients with NSCLC based on two years survival
Source: Annual Congress 2007 - Lung neoplasms
Year: 2007
Prognostic nutritional index (PNI): A predictive factor for elderly patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate
Source: Eur Respir J 2010; 35: 768-775
Year: 2010
Muscle dysfunction in COPD patients associates with HLA system: risk and protective genotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 363s
Year: 2005
Immunological factors in NSCLC patients with possible predictive and prognostic value under PDL-1 treatment-a pilot study
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Prognostic factors in tuberculosis related mortalities in hospitalized patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Prognostic value of neutrophil-to-lymphocyte ratio in hospitalized patients with COVID-19
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
HLA genotype systems in patients with an advancing course of tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Blood leukocyte levels as potential prognostic markers in IPF
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept